RUNX1 and acute myeloid leukemia: Although Lin et al. showed that AS1842856 inhibits the proliferation of AML1-ETO-expressing AML cell lines, the efficiency of the compound against other mutation statuses of AML and the mechanistic action has not been elucidated [15].